Press Releases

Follow us on Twitter | RSS Feeds
04 Mar '24
Veradigm Completes Acquisition of ScienceIO
CHICAGO --(BUSINESS WIRE)--Mar. 4, 2024-- Veradigm Inc. (OTCMKTS: MDRX) (the “Company”), a leading provider of healthcare data and technology products and solutions, today announced that it has completed its acquisition of ScienceIO, a leading AI platform and foundation model provider for the
PDF Version
28 Feb '24
Veradigm Receives Expected Delisting Notice from Nasdaq
Continues to Work Diligently Towards Regaining Compliance CHICAGO --(BUSINESS WIRE)--Feb. 28, 2024-- Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, announced today that, as expected, it received a notice from The Nasdaq Stock Market LLC
PDF Version
28 Feb '24
Veradigm to Participate in TD Cowen Annual Health Care Conference
CHICAGO --(BUSINESS WIRE)--Feb. 28, 2024-- Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, today announced that Dr. Yin Ho , Veradigm interim Chief Executive Officer, and Lee Westerfield , interim Chief Financial Officer, will present at
PDF Version
27 Feb '24
Veradigm to Acquire ScienceIO
Veradigm to Leverage ScienceIO’s Leading Healthcare Artificial Intelligence (AI) Platform on the Company’s Large-Scale, High-Quality Data Set to Build Advanced, Private Language Models for Healthcare Expected to Provide Highly Differentiated and More Advanced Products to Veradigm Customers
PDF Version

Contact Investor Relations

Steven Halper
Vice President, Investor Relations
steven.halper@veradigm.com